Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.
about
Esmolol modulates inhibitory neurotransmission in the substantia gelatinosa of the spinal trigeminal nucleus of the ratInvestigational pharmacology for low back pain.The sciatic nerve cuffing model of neuropathic pain in mice.Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: engagement of spinal serotonergic systemGenetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome.Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.Anti-inflammatory and antinociceptive effects of salbutamol on acute and chronic models of inflammation in rats: involvement of an antioxidant mechanism.Relationship of brown adipose tissue perfusion and function: a study through β2-adrenoreceptor stimulation.Janus molecule I: dichotomous effects of COMT in neuropathic vs nociceptive pain modalities.The antinociceptive effects of ferulic acid on neuropathic pain: involvement of descending monoaminergic system and opioid receptors.Drug repositioning: playing dirty to kill pain.Effects of β2 agonists on post-thoracotomy pain incidence.The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.[1 + 1 = 0. Reprogramming of nociceptors].A β1/2 adrenergic receptor-sensitive intracellular signaling pathway modulates CCL2 production in cultured spinal astrocytes.
P2860
Q34010258-8417A604-B281-4136-8704-B245D8F40EA9Q34418362-17090263-3CA4-410E-8F2C-EA47522A900FQ34442972-ED215620-D5E8-4DE4-8848-4544EFAC96E5Q35169472-F9BE5DE1-4FF3-43E9-8574-086FACA80456Q35431288-A92861E4-BF46-48FD-8ED6-85045684469BQ35606660-AD9B58D5-F20D-4BF0-844C-3AF073125E13Q35991170-C3EF3C46-54AB-4248-B1E1-FDFAA5EA8643Q36810665-1CF43ACA-2A22-41D0-9773-1DB7ACC155F1Q36972453-5BA55347-7B63-488A-8D1A-1F39A3C611AAQ37190334-6B069F19-50AB-410C-84E5-FF8391DDB367Q38170322-28A7E535-20CD-450B-A773-6825FC645B9BQ41232343-54908E78-4EF4-444A-97A5-0EF463DDBA77Q41417230-0BC2725E-3F64-422D-936A-0958725D82D6Q54332066-48B64363-25EA-4D18-9557-8EE1FE0DD944Q54408970-39C0D988-E033-4C27-828F-9E22867F39F8
P2860
Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@ast
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@en
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@nl
type
label
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@ast
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@en
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@nl
prefLabel
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@ast
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@en
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@nl
P2093
P2860
P1476
Beta2-adrenoceptor agonists al ...... mice after chronic treatment.
@en
P2093
Elisabeth Waltisperger
Jean-Luc Rodeau
Marie-José Freund-Mercier
Michel Barrot
Nada Choucair-Jaafar
P2860
P304
P356
10.1111/J.1476-5381.2009.00510.X
P407
P50
P577
2009-12-01T00:00:00Z